GATIS score for predicting the prognosis of rectal neuroendocrine neoplasms: A Chinese multicenter study of 12-year experience

World J Gastroenterol. 2024 Jul 28;30(28):3403-3417. doi: 10.3748/wjg.v30.i28.3403.

Abstract

Background: There is currently a shortage of accurate, efficient, and precise predictive instruments for rectal neuroendocrine neoplasms (NENs).

Aim: To develop a predictive model for individuals with rectal NENs (R-NENs) using data from a large cohort.

Methods: Data from patients with primary R-NENs were retrospectively collected from 17 large-scale referral medical centers in China. Random forest and Cox proportional hazard models were used to identify the risk factors for overall survival and progression-free survival, and two nomograms were constructed.

Results: A total of 1408 patients with R-NENs were included. Tumor grade, T stage, tumor size, age, and a prognostic nutritional index were important risk factors for prognosis. The GATIS score was calculated based on these five indicators. For overall survival prediction, the respective C-indexes in the training set were 0.915 (95% confidence interval: 0.866-0.964) for overall survival prediction and 0.908 (95% confidence interval: 0.872-0.944) for progression-free survival prediction. According to decision curve analysis, net benefit of the GATIS score was higher than that of a single factor. The time-dependent area under the receiver operating characteristic curve showed that the predictive power of the GATIS score was higher than that of the TNM stage and pathological grade at all time periods.

Conclusion: The GATIS score had a good predictive effect on the prognosis of patients with R-NENs, with efficacy superior to that of the World Health Organization grade and TNM stage.

Keywords: Nomogram; Overall survival; Prognosis; Progression-free survival; Random forest; Rectal neuroendocrine neoplasm.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • China / epidemiology
  • East Asian People
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging*
  • Neuroendocrine Tumors* / diagnosis
  • Neuroendocrine Tumors* / mortality
  • Neuroendocrine Tumors* / pathology
  • Neuroendocrine Tumors* / therapy
  • Nomograms*
  • Nutrition Assessment
  • Predictive Value of Tests
  • Prognosis
  • Progression-Free Survival
  • Proportional Hazards Models
  • ROC Curve
  • Rectal Neoplasms* / mortality
  • Rectal Neoplasms* / pathology
  • Rectal Neoplasms* / therapy
  • Retrospective Studies
  • Risk Assessment / methods
  • Risk Factors